Nivolumab (nivo) vs docetaxel (doc) in patients (pts) with advanced NSCLC: CheckMate 017/057 2-y update and exploratory cytokine profile analyses Meeting Abstract
| Authors: | Borghaei, H.; Brahmer, J. R.; Horn, L.; Ready, N.; Steins, M.; Felip, E.; Paz-Ares, L. G.; Arrieta, O.; Barlesi, F.; Antonia, S. J.; Fayette, J.; Rizvi, N. A.; Crino, L.; Reck, M.; Eberhardt, W. E. E.; Hellmann, M. D.; Desal, K.; Li, A.; Healey, D. I.; Spigel, D. R. |
| Abstract Title: | Nivolumab (nivo) vs docetaxel (doc) in patients (pts) with advanced NSCLC: CheckMate 017/057 2-y update and exploratory cytokine profile analyses |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 462s |
| Language: | English |
| ACCESSION: | WOS:000404711506173 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.9025 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9025 -- Source: Wos |
